Arteriosclerotic disorders are frequently observed in diabetics and obviously play an important role in the prognosis in these patients. It is unclear whether the diabetes affects the arteries in an independent, characteristic risk factor fashion or whether the susceptibility to other risk factors is involved. The frequency of cardiovascular death in diabetics is over 70% in the U.S.A. while the percentage is 40-50 in Japan. In statistics found in the autopsy reports published by the Japan Society of Pathology in 1975, deaths due to myocardial and cerebral infarction in diabetics were, respectively, two to three times higher than in non-diabetics. This ratio was compatible with that of most other countries. The Framingham study indicated that a high incidence of cardiovascular disease in diabetics could not be explained simply by the frequency of each risk factor. Thus, diabetes is considered to play the role of an independent risk factor in arteriosclerotic-related diseases.Specific mechanisms of regulation of blood pressure and hypertension in diabetics have been well discussed by Christlieb and other workers. Hyaline degeneration of renal arterioles which often parallels the low renin states often occurs in the initial stage of diabetic nephropathy. It has been suggested that hypertension in diabetics is caused by an aggravation of the changes in renal arterioles and the glomeruli, there by inducing a resistance to renal blood flow and disorders in the compensatory regulation of the renin-angiotensin-aldosterone system. From our observations, both basal and stimulated renin activities were lower in diabetics, especially those who had an accompanying retinopathy and proteinuria, as compared to non-diabetics. The ratio of aldosterone to renin, however, was rather high in diabetics, as determined after upright position and intravenous injection of furosemide. In the regulation of blood pressure in diabetics, disorders in aldosterone and renin secretion were thus considered to play an important role and the clinical application for anti-aldosterone agents should probably be reevaluated.Attention has been focused on platelet function as related to mechanisms of thrombus formation in arteriosclerotic lesions. Recently, we determined thromboxane B2 levels in plasma from diabetics by a radioimmunoassay method of our own design. These levels in diabetics were found to be significantly higher than in the non-diabetics controls, and such findings imply that the turnover of platelets and the release of thromboxane A2 from platelets are accelerated in diabetics. On the other hand, Silberbauer reported that the content of prostacyclin in the vessel wall was decreased in diabetics. Thus, prostaglandin metabolism in platelets and vessels plays an important role in diabetic angiopathy.Enhancement of adhesion and aggregation of platelets have long been evidenced in diabetics. In our patients also there was an enhancement of platelet aggregation, particularly in those with retinopathy and this enhacement decreased in the insulin-treated patients to a much greater extent than in those treated with only diet or oral agents. Enhancement of platelet aggregation was also found in the low insulin response group during 50g OGTT and was improved after intravenous administration of insulin, 0.05 units per kilogram of body weight, while there were no significant alterations in blood sugar and plasma insulin levels. The addition of 100 and 1, 000μU of insulin to platelet rich plasma suppressed significantly adrenaline-induced platelet aggregation. Further experiments revealed the existence of specific binding sites of insulin, insulin receptors, in the platelets themselves. Platelet aggregability was followed up for two years in diabetics treated with diet alone and in those given insulin.